nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—ABCB1—melanoma	0.313	1	CbGaD
Enalapril—SLC22A7—Docetaxel—melanoma	0.149	0.384	CbGbCtD
Enalapril—CYP3A4—Temozolomide—melanoma	0.0899	0.232	CbGbCtD
Enalapril—ABCB1—Dactinomycin—melanoma	0.0547	0.141	CbGbCtD
Enalapril—CYP3A4—Vemurafenib—melanoma	0.0493	0.127	CbGbCtD
Enalapril—ABCB1—Docetaxel—melanoma	0.0282	0.0727	CbGbCtD
Enalapril—CYP3A4—Docetaxel—melanoma	0.0169	0.0436	CbGbCtD
Enalapril—SLC22A8—optic choroid—melanoma	0.0069	0.15	CbGeAlD
Enalapril—ACE—umbilical vein—melanoma	0.00595	0.129	CbGeAlD
Enalapril—ACE—hindlimb—melanoma	0.00545	0.118	CbGeAlD
Enalapril—ACE—arm—melanoma	0.0052	0.113	CbGeAlD
Enalapril—ACE—appendage—melanoma	0.00467	0.101	CbGeAlD
Enalapril—ACE—endothelium—melanoma	0.00282	0.0612	CbGeAlD
Enalapril—ACE—blood vessel—melanoma	0.0026	0.0565	CbGeAlD
Enalapril—Captopril—MMP2—melanoma	0.00202	0.138	CrCbGaD
Enalapril—ACE—neck—melanoma	0.00186	0.0404	CbGeAlD
Enalapril—SLC15A1—mammalian vulva—melanoma	0.00153	0.0333	CbGeAlD
Enalapril—SLC22A8—eye—melanoma	0.00139	0.0302	CbGeAlD
Enalapril—ACE—eye—melanoma	0.00138	0.03	CbGeAlD
Enalapril—Captopril—MMP9—melanoma	0.00133	0.091	CrCbGaD
Enalapril—Fosinopril—SLC15A2—melanoma	0.00133	0.0907	CrCbGaD
Enalapril—ACE—mammalian vulva—melanoma	0.0011	0.0238	CbGeAlD
Enalapril—Perindopril—SLC15A2—melanoma	0.00108	0.074	CrCbGaD
Enalapril—Spirapril—SLC15A2—melanoma	0.00107	0.0731	CrCbGaD
Enalapril—Moexipril—SLC15A2—melanoma	0.00102	0.0701	CrCbGaD
Enalapril—Quinapril—SLC15A2—melanoma	0.000953	0.0652	CrCbGaD
Enalapril—Cilazapril—SLC15A2—melanoma	0.000953	0.0652	CrCbGaD
Enalapril—Trandolapril—SLC15A2—melanoma	0.000923	0.0631	CrCbGaD
Enalapril—Ramipril—SLC15A2—melanoma	0.000923	0.0631	CrCbGaD
Enalapril—ABCB1—blood vessel—melanoma	0.000915	0.0199	CbGeAlD
Enalapril—Benazepril—SLC15A2—melanoma	0.000829	0.0567	CrCbGaD
Enalapril—SLCO1A2—head—melanoma	0.000826	0.0179	CbGeAlD
Enalapril—SLC22A8—head—melanoma	0.000788	0.0171	CbGeAlD
Enalapril—ACE—head—melanoma	0.000786	0.0171	CbGeAlD
Enalapril—Urinary tract infection—Carmustine—melanoma	0.00064	0.00314	CcSEcCtD
Enalapril—Pneumonia—Temozolomide—melanoma	0.00064	0.00314	CcSEcCtD
Enalapril—Depression—Temozolomide—melanoma	0.000634	0.00311	CcSEcCtD
Enalapril—Hepatitis—Dactinomycin—melanoma	0.000631	0.0031	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00063	0.0031	CcSEcCtD
Enalapril—Flushing—Bleomycin—melanoma	0.000628	0.00308	CcSEcCtD
Enalapril—Body temperature increased—Vemurafenib—melanoma	0.000627	0.00308	CcSEcCtD
Enalapril—Pharyngitis—Dactinomycin—melanoma	0.000626	0.00308	CcSEcCtD
Enalapril—Neuropathy peripheral—Temozolomide—melanoma	0.000623	0.00306	CcSEcCtD
Enalapril—Swelling—Docetaxel—melanoma	0.000622	0.00306	CcSEcCtD
Enalapril—Stomatitis—Temozolomide—melanoma	0.00062	0.00304	CcSEcCtD
Enalapril—Urinary tract infection—Temozolomide—melanoma	0.000618	0.00304	CcSEcCtD
Enalapril—Deafness—Docetaxel—melanoma	0.000613	0.00301	CcSEcCtD
Enalapril—Hepatic failure—Docetaxel—melanoma	0.000611	0.003	CcSEcCtD
Enalapril—Alopecia—Bleomycin—melanoma	0.000598	0.00294	CcSEcCtD
Enalapril—Erythema multiforme—Dactinomycin—melanoma	0.000597	0.00293	CcSEcCtD
Enalapril—Sinusitis—Temozolomide—melanoma	0.000597	0.00293	CcSEcCtD
Enalapril—Erythema—Bleomycin—melanoma	0.000589	0.00289	CcSEcCtD
Enalapril—Hot flush—Docetaxel—melanoma	0.000587	0.00288	CcSEcCtD
Enalapril—Flushing—Dactinomycin—melanoma	0.000586	0.00288	CcSEcCtD
Enalapril—Hypersensitivity—Vemurafenib—melanoma	0.000585	0.00287	CcSEcCtD
Enalapril—Menopausal symptoms—Docetaxel—melanoma	0.000582	0.00286	CcSEcCtD
Enalapril—Atrial fibrillation—Docetaxel—melanoma	0.000579	0.00284	CcSEcCtD
Enalapril—Visual disturbance—Docetaxel—melanoma	0.000579	0.00284	CcSEcCtD
Enalapril—Hepatitis—Temozolomide—melanoma	0.000571	0.0028	CcSEcCtD
Enalapril—Asthenia—Vemurafenib—melanoma	0.000569	0.0028	CcSEcCtD
Enalapril—Visual impairment—Carmustine—melanoma	0.000569	0.0028	CcSEcCtD
Enalapril—Pharyngitis—Temozolomide—melanoma	0.000567	0.00278	CcSEcCtD
Enalapril—Pruritus—Vemurafenib—melanoma	0.000561	0.00276	CcSEcCtD
Enalapril—Alopecia—Dactinomycin—melanoma	0.000558	0.00274	CcSEcCtD
Enalapril—Hyponatraemia—Docetaxel—melanoma	0.000551	0.00271	CcSEcCtD
Enalapril—Visual impairment—Temozolomide—melanoma	0.00055	0.0027	CcSEcCtD
Enalapril—ACE—lymph node—melanoma	0.00055	0.0119	CbGeAlD
Enalapril—Erythema—Dactinomycin—melanoma	0.000549	0.0027	CcSEcCtD
Enalapril—Pain in extremity—Docetaxel—melanoma	0.000549	0.0027	CcSEcCtD
Enalapril—Flushing—Carmustine—melanoma	0.000548	0.00269	CcSEcCtD
Enalapril—Anaemia—Bleomycin—melanoma	0.000544	0.00267	CcSEcCtD
Enalapril—Diarrhoea—Vemurafenib—melanoma	0.000543	0.00267	CcSEcCtD
Enalapril—Erythema multiforme—Temozolomide—melanoma	0.00054	0.00265	CcSEcCtD
Enalapril—Tinnitus—Temozolomide—melanoma	0.000532	0.00261	CcSEcCtD
Enalapril—Flushing—Temozolomide—melanoma	0.00053	0.0026	CcSEcCtD
Enalapril—Arrhythmia—Carmustine—melanoma	0.000528	0.00259	CcSEcCtD
Enalapril—Leukopenia—Bleomycin—melanoma	0.000527	0.00259	CcSEcCtD
Enalapril—Dizziness—Vemurafenib—melanoma	0.000525	0.00258	CcSEcCtD
Enalapril—Alopecia—Carmustine—melanoma	0.000522	0.00256	CcSEcCtD
Enalapril—Ataxia—Docetaxel—melanoma	0.000516	0.00253	CcSEcCtD
Enalapril—Erythema—Carmustine—melanoma	0.000514	0.00253	CcSEcCtD
Enalapril—Cough—Bleomycin—melanoma	0.000514	0.00252	CcSEcCtD
Enalapril—Anaemia—Dactinomycin—melanoma	0.000508	0.00249	CcSEcCtD
Enalapril—Vomiting—Vemurafenib—melanoma	0.000505	0.00248	CcSEcCtD
Enalapril—Alopecia—Temozolomide—melanoma	0.000504	0.00248	CcSEcCtD
Enalapril—Dry skin—Docetaxel—melanoma	0.000503	0.00247	CcSEcCtD
Enalapril—Myalgia—Bleomycin—melanoma	0.000502	0.00246	CcSEcCtD
Enalapril—Chest pain—Bleomycin—melanoma	0.000502	0.00246	CcSEcCtD
Enalapril—Orthostatic hypotension—Docetaxel—melanoma	0.000501	0.00246	CcSEcCtD
Enalapril—Rash—Vemurafenib—melanoma	0.0005	0.00246	CcSEcCtD
Enalapril—Dermatitis—Vemurafenib—melanoma	0.0005	0.00246	CcSEcCtD
Enalapril—Back pain—Carmustine—melanoma	0.000497	0.00244	CcSEcCtD
Enalapril—Headache—Vemurafenib—melanoma	0.000497	0.00244	CcSEcCtD
Enalapril—Erythema—Temozolomide—melanoma	0.000497	0.00244	CcSEcCtD
Enalapril—Discomfort—Bleomycin—melanoma	0.000496	0.00243	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000494	0.00243	CcSEcCtD
Enalapril—Cramp muscle—Docetaxel—melanoma	0.000494	0.00243	CcSEcCtD
Enalapril—Leukopenia—Dactinomycin—melanoma	0.000492	0.00242	CcSEcCtD
Enalapril—Nasopharyngitis—Docetaxel—melanoma	0.000491	0.00241	CcSEcCtD
Enalapril—Dysgeusia—Temozolomide—melanoma	0.000487	0.00239	CcSEcCtD
Enalapril—Confusional state—Bleomycin—melanoma	0.000485	0.00238	CcSEcCtD
Enalapril—Vision blurred—Carmustine—melanoma	0.000485	0.00238	CcSEcCtD
Enalapril—Alanine aminotransferase increased—Docetaxel—melanoma	0.000484	0.00238	CcSEcCtD
Enalapril—ABCB1—retina—melanoma	0.000483	0.0105	CbGeAlD
Enalapril—Tremor—Carmustine—melanoma	0.000482	0.00237	CcSEcCtD
Enalapril—Anaphylactic shock—Bleomycin—melanoma	0.000481	0.00236	CcSEcCtD
Enalapril—Oedema—Bleomycin—melanoma	0.000481	0.00236	CcSEcCtD
Enalapril—Back pain—Temozolomide—melanoma	0.000481	0.00236	CcSEcCtD
Enalapril—Nateglinide—SLC15A2—melanoma	0.000478	0.0327	CrCbGaD
Enalapril—Anaemia—Carmustine—melanoma	0.000475	0.00233	CcSEcCtD
Enalapril—Dysphagia—Docetaxel—melanoma	0.000474	0.00233	CcSEcCtD
Enalapril—Agitation—Carmustine—melanoma	0.000473	0.00232	CcSEcCtD
Enalapril—Nausea—Vemurafenib—melanoma	0.000471	0.00232	CcSEcCtD
Enalapril—Thrombocytopenia—Bleomycin—melanoma	0.000471	0.00231	CcSEcCtD
Enalapril—Vision blurred—Temozolomide—melanoma	0.000468	0.0023	CcSEcCtD
Enalapril—Myalgia—Dactinomycin—melanoma	0.000468	0.0023	CcSEcCtD
Enalapril—Bronchospasm—Docetaxel—melanoma	0.000467	0.00229	CcSEcCtD
Enalapril—Tremor—Temozolomide—melanoma	0.000466	0.00229	CcSEcCtD
Enalapril—Discomfort—Dactinomycin—melanoma	0.000462	0.00227	CcSEcCtD
Enalapril—Angina pectoris—Docetaxel—melanoma	0.000462	0.00227	CcSEcCtD
Enalapril—Leukopenia—Carmustine—melanoma	0.00046	0.00226	CcSEcCtD
Enalapril—Anaemia—Temozolomide—melanoma	0.000459	0.00226	CcSEcCtD
Enalapril—Anorexia—Bleomycin—melanoma	0.000458	0.00225	CcSEcCtD
Enalapril—Agitation—Temozolomide—melanoma	0.000457	0.00224	CcSEcCtD
Enalapril—Angioedema—Temozolomide—melanoma	0.000454	0.00223	CcSEcCtD
Enalapril—Pancytopenia—Docetaxel—melanoma	0.00045	0.00221	CcSEcCtD
Enalapril—Hypotension—Bleomycin—melanoma	0.000449	0.00221	CcSEcCtD
Enalapril—Oedema—Dactinomycin—melanoma	0.000448	0.0022	CcSEcCtD
Enalapril—Vertigo—Temozolomide—melanoma	0.000446	0.00219	CcSEcCtD
Enalapril—Leukopenia—Temozolomide—melanoma	0.000445	0.00218	CcSEcCtD
Enalapril—Neutropenia—Docetaxel—melanoma	0.000443	0.00218	CcSEcCtD
Enalapril—Palpitations—Temozolomide—melanoma	0.000439	0.00216	CcSEcCtD
Enalapril—Thrombocytopenia—Dactinomycin—melanoma	0.000439	0.00216	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Bleomycin—melanoma	0.000438	0.00215	CcSEcCtD
Enalapril—Myalgia—Carmustine—melanoma	0.000438	0.00215	CcSEcCtD
Enalapril—Chest pain—Carmustine—melanoma	0.000438	0.00215	CcSEcCtD
Enalapril—Cough—Temozolomide—melanoma	0.000434	0.00213	CcSEcCtD
Enalapril—Paraesthesia—Bleomycin—melanoma	0.000432	0.00212	CcSEcCtD
Enalapril—Dyspnoea—Bleomycin—melanoma	0.000429	0.00211	CcSEcCtD
Enalapril—Anorexia—Dactinomycin—melanoma	0.000427	0.0021	CcSEcCtD
Enalapril—Pneumonia—Docetaxel—melanoma	0.000425	0.00209	CcSEcCtD
Enalapril—Confusional state—Carmustine—melanoma	0.000423	0.00208	CcSEcCtD
Enalapril—Arthralgia—Temozolomide—melanoma	0.000423	0.00208	CcSEcCtD
Enalapril—Myalgia—Temozolomide—melanoma	0.000423	0.00208	CcSEcCtD
Enalapril—Oedema—Carmustine—melanoma	0.00042	0.00206	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000419	0.00206	CcSEcCtD
Enalapril—Discomfort—Temozolomide—melanoma	0.000418	0.00205	CcSEcCtD
Enalapril—Decreased appetite—Bleomycin—melanoma	0.000418	0.00205	CcSEcCtD
Enalapril—Acute coronary syndrome—Docetaxel—melanoma	0.000417	0.00205	CcSEcCtD
Enalapril—Renal failure—Docetaxel—melanoma	0.000416	0.00204	CcSEcCtD
Enalapril—Myocardial infarction—Docetaxel—melanoma	0.000415	0.00204	CcSEcCtD
Enalapril—Neuropathy peripheral—Docetaxel—melanoma	0.000415	0.00204	CcSEcCtD
Enalapril—Dry mouth—Temozolomide—melanoma	0.000414	0.00203	CcSEcCtD
Enalapril—Stomatitis—Docetaxel—melanoma	0.000412	0.00202	CcSEcCtD
Enalapril—Jaundice—Docetaxel—melanoma	0.000412	0.00202	CcSEcCtD
Enalapril—Conjunctivitis—Docetaxel—melanoma	0.000411	0.00202	CcSEcCtD
Enalapril—Thrombocytopenia—Carmustine—melanoma	0.000411	0.00202	CcSEcCtD
Enalapril—Tachycardia—Carmustine—melanoma	0.00041	0.00201	CcSEcCtD
Enalapril—Confusional state—Temozolomide—melanoma	0.000409	0.00201	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000409	0.00201	CcSEcCtD
Enalapril—Oedema—Temozolomide—melanoma	0.000406	0.00199	CcSEcCtD
Enalapril—Anaphylactic shock—Temozolomide—melanoma	0.000406	0.00199	CcSEcCtD
Enalapril—Anorexia—Carmustine—melanoma	0.0004	0.00196	CcSEcCtD
Enalapril—Epistaxis—Docetaxel—melanoma	0.000399	0.00196	CcSEcCtD
Enalapril—Thrombocytopenia—Temozolomide—melanoma	0.000397	0.00195	CcSEcCtD
Enalapril—Feeling abnormal—Bleomycin—melanoma	0.000396	0.00195	CcSEcCtD
Enalapril—Agranulocytosis—Docetaxel—melanoma	0.000395	0.00194	CcSEcCtD
Enalapril—Hypotension—Carmustine—melanoma	0.000392	0.00193	CcSEcCtD
Enalapril—Hyperhidrosis—Temozolomide—melanoma	0.000392	0.00193	CcSEcCtD
Enalapril—Decreased appetite—Dactinomycin—melanoma	0.00039	0.00191	CcSEcCtD
Enalapril—Fatigue—Dactinomycin—melanoma	0.000387	0.0019	CcSEcCtD
Enalapril—Anorexia—Temozolomide—melanoma	0.000387	0.0019	CcSEcCtD
Enalapril—ABCB1—mammalian vulva—melanoma	0.000387	0.00839	CbGeAlD
Enalapril—Musculoskeletal discomfort—Carmustine—melanoma	0.000382	0.00188	CcSEcCtD
Enalapril—Urticaria—Bleomycin—melanoma	0.000382	0.00188	CcSEcCtD
Enalapril—Body temperature increased—Bleomycin—melanoma	0.00038	0.00187	CcSEcCtD
Enalapril—Hepatitis—Docetaxel—melanoma	0.00038	0.00186	CcSEcCtD
Enalapril—Insomnia—Carmustine—melanoma	0.00038	0.00186	CcSEcCtD
Enalapril—Paraesthesia—Carmustine—melanoma	0.000377	0.00185	CcSEcCtD
Enalapril—Pharyngitis—Docetaxel—melanoma	0.000377	0.00185	CcSEcCtD
Enalapril—Dyspnoea—Carmustine—melanoma	0.000374	0.00184	CcSEcCtD
Enalapril—Somnolence—Carmustine—melanoma	0.000373	0.00183	CcSEcCtD
Enalapril—Captopril—ALB—melanoma	0.00037	0.0253	CrCbGaD
Enalapril—Feeling abnormal—Dactinomycin—melanoma	0.000369	0.00181	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Temozolomide—melanoma	0.000369	0.00181	CcSEcCtD
Enalapril—Insomnia—Temozolomide—melanoma	0.000367	0.0018	CcSEcCtD
Enalapril—Gastrointestinal pain—Dactinomycin—melanoma	0.000367	0.0018	CcSEcCtD
Enalapril—Visual impairment—Docetaxel—melanoma	0.000366	0.0018	CcSEcCtD
Enalapril—Decreased appetite—Carmustine—melanoma	0.000365	0.00179	CcSEcCtD
Enalapril—Paraesthesia—Temozolomide—melanoma	0.000364	0.00179	CcSEcCtD
Enalapril—Dyspnoea—Temozolomide—melanoma	0.000362	0.00178	CcSEcCtD
Enalapril—Somnolence—Temozolomide—melanoma	0.000361	0.00177	CcSEcCtD
Enalapril—Erythema multiforme—Docetaxel—melanoma	0.000359	0.00176	CcSEcCtD
Enalapril—Constipation—Carmustine—melanoma	0.000359	0.00176	CcSEcCtD
Enalapril—Dyspepsia—Temozolomide—melanoma	0.000357	0.00175	CcSEcCtD
Enalapril—Body temperature increased—Dactinomycin—melanoma	0.000354	0.00174	CcSEcCtD
Enalapril—Abdominal pain—Dactinomycin—melanoma	0.000354	0.00174	CcSEcCtD
Enalapril—Hypersensitivity—Bleomycin—melanoma	0.000354	0.00174	CcSEcCtD
Enalapril—Captopril—ABCB1—melanoma	0.000353	0.0241	CrCbGaD
Enalapril—Decreased appetite—Temozolomide—melanoma	0.000353	0.00173	CcSEcCtD
Enalapril—Flushing—Docetaxel—melanoma	0.000352	0.00173	CcSEcCtD
Enalapril—Fatigue—Temozolomide—melanoma	0.00035	0.00172	CcSEcCtD
Enalapril—Constipation—Temozolomide—melanoma	0.000347	0.0017	CcSEcCtD
Enalapril—Feeling abnormal—Carmustine—melanoma	0.000346	0.0017	CcSEcCtD
Enalapril—Asthenia—Bleomycin—melanoma	0.000345	0.00169	CcSEcCtD
Enalapril—Gastrointestinal pain—Carmustine—melanoma	0.000343	0.00169	CcSEcCtD
Enalapril—Pruritus—Bleomycin—melanoma	0.00034	0.00167	CcSEcCtD
Enalapril—Arrhythmia—Docetaxel—melanoma	0.000339	0.00167	CcSEcCtD
Enalapril—Alopecia—Docetaxel—melanoma	0.000335	0.00165	CcSEcCtD
Enalapril—Feeling abnormal—Temozolomide—melanoma	0.000334	0.00164	CcSEcCtD
Enalapril—Body temperature increased—Carmustine—melanoma	0.000332	0.00163	CcSEcCtD
Enalapril—Abdominal pain—Carmustine—melanoma	0.000332	0.00163	CcSEcCtD
Enalapril—Gastrointestinal pain—Temozolomide—melanoma	0.000332	0.00163	CcSEcCtD
Enalapril—Erythema—Docetaxel—melanoma	0.00033	0.00162	CcSEcCtD
Enalapril—Hypersensitivity—Dactinomycin—melanoma	0.00033	0.00162	CcSEcCtD
Enalapril—Dysgeusia—Docetaxel—melanoma	0.000324	0.00159	CcSEcCtD
Enalapril—Urticaria—Temozolomide—melanoma	0.000322	0.00158	CcSEcCtD
Enalapril—Asthenia—Dactinomycin—melanoma	0.000322	0.00158	CcSEcCtD
Enalapril—Abdominal pain—Temozolomide—melanoma	0.000321	0.00157	CcSEcCtD
Enalapril—Body temperature increased—Temozolomide—melanoma	0.000321	0.00157	CcSEcCtD
Enalapril—Back pain—Docetaxel—melanoma	0.00032	0.00157	CcSEcCtD
Enalapril—Muscle spasms—Docetaxel—melanoma	0.000318	0.00156	CcSEcCtD
Enalapril—Hypersensitivity—Carmustine—melanoma	0.000309	0.00152	CcSEcCtD
Enalapril—Diarrhoea—Dactinomycin—melanoma	0.000307	0.00151	CcSEcCtD
Enalapril—Vomiting—Bleomycin—melanoma	0.000306	0.0015	CcSEcCtD
Enalapril—Anaemia—Docetaxel—melanoma	0.000305	0.0015	CcSEcCtD
Enalapril—Rash—Bleomycin—melanoma	0.000303	0.00149	CcSEcCtD
Enalapril—Dermatitis—Bleomycin—melanoma	0.000303	0.00149	CcSEcCtD
Enalapril—Asthenia—Carmustine—melanoma	0.000301	0.00148	CcSEcCtD
Enalapril—Hypersensitivity—Temozolomide—melanoma	0.000299	0.00147	CcSEcCtD
Enalapril—Syncope—Docetaxel—melanoma	0.000296	0.00146	CcSEcCtD
Enalapril—Leukopenia—Docetaxel—melanoma	0.000296	0.00145	CcSEcCtD
Enalapril—Palpitations—Docetaxel—melanoma	0.000292	0.00143	CcSEcCtD
Enalapril—Asthenia—Temozolomide—melanoma	0.000291	0.00143	CcSEcCtD
Enalapril—Loss of consciousness—Docetaxel—melanoma	0.00029	0.00143	CcSEcCtD
Enalapril—Cough—Docetaxel—melanoma	0.000288	0.00142	CcSEcCtD
Enalapril—Diarrhoea—Carmustine—melanoma	0.000287	0.00141	CcSEcCtD
Enalapril—Pruritus—Temozolomide—melanoma	0.000287	0.00141	CcSEcCtD
Enalapril—Nausea—Bleomycin—melanoma	0.000286	0.0014	CcSEcCtD
Enalapril—Vomiting—Dactinomycin—melanoma	0.000285	0.0014	CcSEcCtD
Enalapril—Rash—Dactinomycin—melanoma	0.000283	0.00139	CcSEcCtD
Enalapril—Myalgia—Docetaxel—melanoma	0.000281	0.00138	CcSEcCtD
Enalapril—Chest pain—Docetaxel—melanoma	0.000281	0.00138	CcSEcCtD
Enalapril—Arthralgia—Docetaxel—melanoma	0.000281	0.00138	CcSEcCtD
Enalapril—Dizziness—Carmustine—melanoma	0.000278	0.00136	CcSEcCtD
Enalapril—Diarrhoea—Temozolomide—melanoma	0.000277	0.00136	CcSEcCtD
Enalapril—ABCB1—head—melanoma	0.000277	0.00601	CbGeAlD
Enalapril—Dry mouth—Docetaxel—melanoma	0.000275	0.00135	CcSEcCtD
Enalapril—Nateglinide—PPARG—melanoma	0.000273	0.0187	CrCbGaD
Enalapril—Confusional state—Docetaxel—melanoma	0.000272	0.00134	CcSEcCtD
Enalapril—Oedema—Docetaxel—melanoma	0.00027	0.00132	CcSEcCtD
Enalapril—Anaphylactic shock—Docetaxel—melanoma	0.00027	0.00132	CcSEcCtD
Enalapril—Dizziness—Temozolomide—melanoma	0.000268	0.00132	CcSEcCtD
Enalapril—Vomiting—Carmustine—melanoma	0.000267	0.00131	CcSEcCtD
Enalapril—Nausea—Dactinomycin—melanoma	0.000266	0.00131	CcSEcCtD
Enalapril—Shock—Docetaxel—melanoma	0.000265	0.0013	CcSEcCtD
Enalapril—Rash—Carmustine—melanoma	0.000265	0.0013	CcSEcCtD
Enalapril—Dermatitis—Carmustine—melanoma	0.000264	0.0013	CcSEcCtD
Enalapril—Thrombocytopenia—Docetaxel—melanoma	0.000264	0.0013	CcSEcCtD
Enalapril—Tachycardia—Docetaxel—melanoma	0.000263	0.00129	CcSEcCtD
Enalapril—Headache—Carmustine—melanoma	0.000263	0.00129	CcSEcCtD
Enalapril—Vomiting—Temozolomide—melanoma	0.000258	0.00127	CcSEcCtD
Enalapril—Anorexia—Docetaxel—melanoma	0.000257	0.00126	CcSEcCtD
Enalapril—Rash—Temozolomide—melanoma	0.000256	0.00126	CcSEcCtD
Enalapril—Dermatitis—Temozolomide—melanoma	0.000255	0.00125	CcSEcCtD
Enalapril—Headache—Temozolomide—melanoma	0.000254	0.00125	CcSEcCtD
Enalapril—Hypotension—Docetaxel—melanoma	0.000252	0.00124	CcSEcCtD
Enalapril—Nausea—Carmustine—melanoma	0.000249	0.00122	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Docetaxel—melanoma	0.000246	0.00121	CcSEcCtD
Enalapril—Insomnia—Docetaxel—melanoma	0.000244	0.0012	CcSEcCtD
Enalapril—Paraesthesia—Docetaxel—melanoma	0.000242	0.00119	CcSEcCtD
Enalapril—Nausea—Temozolomide—melanoma	0.000241	0.00118	CcSEcCtD
Enalapril—Dyspnoea—Docetaxel—melanoma	0.00024	0.00118	CcSEcCtD
Enalapril—Somnolence—Docetaxel—melanoma	0.00024	0.00118	CcSEcCtD
Enalapril—Dyspepsia—Docetaxel—melanoma	0.000237	0.00117	CcSEcCtD
Enalapril—Decreased appetite—Docetaxel—melanoma	0.000234	0.00115	CcSEcCtD
Enalapril—Fatigue—Docetaxel—melanoma	0.000233	0.00114	CcSEcCtD
Enalapril—Constipation—Docetaxel—melanoma	0.000231	0.00113	CcSEcCtD
Enalapril—Feeling abnormal—Docetaxel—melanoma	0.000222	0.00109	CcSEcCtD
Enalapril—Perindopril—ABCB1—melanoma	0.000222	0.0152	CrCbGaD
Enalapril—Gastrointestinal pain—Docetaxel—melanoma	0.000221	0.00108	CcSEcCtD
Enalapril—Abdominal pain—Docetaxel—melanoma	0.000213	0.00105	CcSEcCtD
Enalapril—Body temperature increased—Docetaxel—melanoma	0.000213	0.00105	CcSEcCtD
Enalapril—Hypersensitivity—Docetaxel—melanoma	0.000199	0.000976	CcSEcCtD
Enalapril—Lisinopril—ABCB1—melanoma	0.000196	0.0134	CrCbGaD
Enalapril—Cilazapril—ABCB1—melanoma	0.000196	0.0134	CrCbGaD
Enalapril—ABCB1—lymph node—melanoma	0.000194	0.0042	CbGeAlD
Enalapril—Asthenia—Docetaxel—melanoma	0.000194	0.00095	CcSEcCtD
Enalapril—Pruritus—Docetaxel—melanoma	0.000191	0.000937	CcSEcCtD
Enalapril—Diarrhoea—Docetaxel—melanoma	0.000185	0.000906	CcSEcCtD
Enalapril—Dizziness—Docetaxel—melanoma	0.000178	0.000876	CcSEcCtD
Enalapril—Vomiting—Docetaxel—melanoma	0.000171	0.000842	CcSEcCtD
Enalapril—Rash—Docetaxel—melanoma	0.00017	0.000835	CcSEcCtD
Enalapril—Dermatitis—Docetaxel—melanoma	0.00017	0.000834	CcSEcCtD
Enalapril—Headache—Docetaxel—melanoma	0.000169	0.00083	CcSEcCtD
Enalapril—Nausea—Docetaxel—melanoma	0.00016	0.000787	CcSEcCtD
Enalapril—Nateglinide—ALB—melanoma	0.000103	0.00703	CrCbGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC17A5—melanoma	8.77e-05	0.0025	CbGpPWpGaD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—melanoma	8.59e-05	0.00245	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—PAX6—melanoma	8.51e-05	0.00243	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC6A11—melanoma	8.48e-05	0.00241	CbGpPWpGaD
Enalapril—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	8.2e-05	0.00233	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—HSPA5—melanoma	8.18e-05	0.00233	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CTLA4—melanoma	8.06e-05	0.0023	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC6A11—melanoma	7.97e-05	0.00227	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ABCB5—melanoma	7.9e-05	0.00225	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	7.81e-05	0.00222	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	7.79e-05	0.00222	CbGpPWpGaD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	7.63e-05	0.00217	CbGpPWpGaD
Enalapril—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	7.45e-05	0.00212	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	7.44e-05	0.00212	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	7.37e-05	0.0021	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—EDN1—melanoma	7.32e-05	0.00209	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—melanoma	7.17e-05	0.00204	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	7.15e-05	0.00204	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	7.06e-05	0.00201	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	6.96e-05	0.00198	CbGpPWpGaD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	6.82e-05	0.00194	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	6.57e-05	0.00187	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	6.57e-05	0.00187	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ACER3—melanoma	6.55e-05	0.00187	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CD86—melanoma	6.39e-05	0.00182	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—TERT—melanoma	6.38e-05	0.00182	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL10—melanoma	6.27e-05	0.00179	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	6.1e-05	0.00174	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL4—melanoma	6.1e-05	0.00174	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	6.07e-05	0.00173	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	6.02e-05	0.00171	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—PDGFRA—melanoma	6e-05	0.00171	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—UGT2B10—melanoma	5.99e-05	0.00171	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—HLA-B—melanoma	5.96e-05	0.0017	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	5.94e-05	0.00169	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	5.92e-05	0.00169	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	5.89e-05	0.00168	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	5.87e-05	0.00167	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—FASLG—melanoma	5.83e-05	0.00166	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	5.8e-05	0.00165	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—FAS—melanoma	5.62e-05	0.0016	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	5.58e-05	0.00159	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—HS3ST5—melanoma	5.57e-05	0.00159	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	5.55e-05	0.00158	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—HLA-A—melanoma	5.52e-05	0.00157	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	5.48e-05	0.00156	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	5.43e-05	0.00155	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC5A5—melanoma	5.19e-05	0.00148	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	5.05e-05	0.00144	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	4.91e-05	0.0014	CbGpPWpGaD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	4.9e-05	0.0014	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	4.88e-05	0.00139	CbGpPWpGaD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—ALB—melanoma	4.88e-05	0.00139	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—MMP1—melanoma	4.85e-05	0.00138	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CD80—melanoma	4.66e-05	0.00133	CbGpPWpGaD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	4.61e-05	0.00131	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	4.48e-05	0.00128	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC5A5—melanoma	4.37e-05	0.00124	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CASP8—melanoma	4.33e-05	0.00123	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PLCB4—melanoma	4.22e-05	0.0012	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	4.15e-05	0.00118	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	4.14e-05	0.00118	CbGpPWpGaD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—ALB—melanoma	4.1e-05	0.00117	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	4e-05	0.00114	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SLC6A11—melanoma	3.97e-05	0.00113	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIP4K2A—melanoma	3.97e-05	0.00113	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ABCB1—melanoma	3.96e-05	0.00113	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—melanoma	3.88e-05	0.0011	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—IGF1—melanoma	3.88e-05	0.0011	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—MTAP—melanoma	3.86e-05	0.0011	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.77e-05	0.00107	CbGpPWpGaD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	3.75e-05	0.00107	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—MMP2—melanoma	3.75e-05	0.00107	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	3.74e-05	0.00107	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IFNG—melanoma	3.69e-05	0.00105	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC5A5—melanoma	3.64e-05	0.00104	CbGpPWpGaD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—ALB—melanoma	3.64e-05	0.00104	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	3.63e-05	0.00103	CbGpPWpGaD
Enalapril—CYP3A4—Tryptophan metabolism—MDM2—melanoma	3.48e-05	0.000991	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PHGDH—melanoma	3.44e-05	0.00098	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—LUM—melanoma	3.44e-05	0.00098	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CXCL8—melanoma	3.43e-05	0.000976	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—ALB—melanoma	3.42e-05	0.000974	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—HPSE—melanoma	3.38e-05	0.000961	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ABCB1—melanoma	3.33e-05	0.000948	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CUBN—melanoma	3.31e-05	0.000944	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CASP3—melanoma	3.28e-05	0.000934	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL2—melanoma	3.28e-05	0.000933	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	3.26e-05	0.000929	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	3.21e-05	0.000915	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SDHD—melanoma	3.2e-05	0.000911	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CSPG4—melanoma	3.2e-05	0.000911	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—BSG—melanoma	3.2e-05	0.000911	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—CXCL8—melanoma	3.12e-05	0.000888	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GPAM—melanoma	3.1e-05	0.000883	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP17A1—melanoma	3.08e-05	0.000877	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	3.06e-05	0.000871	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	3.04e-05	0.000865	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	2.99e-05	0.000853	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	2.96e-05	0.000844	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ABCB1—melanoma	2.96e-05	0.000842	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	2.93e-05	0.000835	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	2.88e-05	0.000819	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—CTNNB1—melanoma	2.88e-05	0.000819	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	2.82e-05	0.000804	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ACER3—melanoma	2.8e-05	0.000799	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—VEGFA—melanoma	2.78e-05	0.000793	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ABCB1—melanoma	2.78e-05	0.000791	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	2.77e-05	0.00079	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	2.72e-05	0.000774	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PLA2G6—melanoma	2.64e-05	0.00075	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP1B1—melanoma	2.59e-05	0.000738	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	2.58e-05	0.000735	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—UGT2B10—melanoma	2.57e-05	0.000731	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	2.56e-05	0.000728	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ALB—melanoma	2.48e-05	0.000706	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	2.45e-05	0.000698	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	2.44e-05	0.000695	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—TNF—melanoma	2.39e-05	0.000679	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—HS3ST5—melanoma	2.39e-05	0.000679	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—VCAN—melanoma	2.37e-05	0.000674	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	2.34e-05	0.000667	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	2.3e-05	0.000654	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	2.27e-05	0.000647	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.24e-05	0.000638	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.16e-05	0.000616	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	2.14e-05	0.000609	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	2.1e-05	0.000599	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ALB—melanoma	2.08e-05	0.000593	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	2.05e-05	0.000584	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	2.03e-05	0.000579	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP17A1—melanoma	2e-05	0.000569	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.97e-05	0.000561	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.94e-05	0.000554	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	1.93e-05	0.000551	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GNA11—melanoma	1.89e-05	0.000537	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ALB—melanoma	1.85e-05	0.000527	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—FASN—melanoma	1.85e-05	0.000526	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	1.84e-05	0.000523	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SLC5A5—melanoma	1.82e-05	0.000517	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	1.81e-05	0.000515	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PLCB4—melanoma	1.81e-05	0.000515	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	1.78e-05	0.000508	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GNAQ—melanoma	1.75e-05	0.000499	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CD44—melanoma	1.75e-05	0.000499	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	1.74e-05	0.000497	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	1.74e-05	0.000495	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ACER3—melanoma	1.73e-05	0.000492	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.72e-05	0.000489	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.7e-05	0.000484	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SLC6A11—melanoma	1.7e-05	0.000484	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIP4K2A—melanoma	1.7e-05	0.000484	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP1B1—melanoma	1.68e-05	0.000479	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.66e-05	0.000473	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—MTAP—melanoma	1.65e-05	0.000471	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	1.65e-05	0.00047	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	1.62e-05	0.000461	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—UGT2B10—melanoma	1.58e-05	0.00045	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	1.58e-05	0.000449	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.56e-05	0.000444	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.52e-05	0.000434	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.52e-05	0.000433	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.51e-05	0.000431	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.48e-05	0.000423	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PHGDH—melanoma	1.47e-05	0.00042	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—LUM—melanoma	1.47e-05	0.00042	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—HS3ST5—melanoma	1.47e-05	0.000419	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—HPSE—melanoma	1.44e-05	0.000412	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CUBN—melanoma	1.42e-05	0.000404	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ABCB1—melanoma	1.38e-05	0.000394	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.37e-05	0.000391	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SDHD—melanoma	1.37e-05	0.00039	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—BSG—melanoma	1.37e-05	0.00039	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CSPG4—melanoma	1.37e-05	0.00039	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GPAM—melanoma	1.33e-05	0.000378	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.3e-05	0.00037	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PRKCA—melanoma	1.27e-05	0.000363	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.26e-05	0.00036	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ERCC2—melanoma	1.26e-05	0.00036	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.24e-05	0.000352	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.24e-05	0.000352	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.18e-05	0.000335	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.17e-05	0.000333	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PLA2G6—melanoma	1.13e-05	0.000321	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PLCB4—melanoma	1.11e-05	0.000317	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.07e-05	0.000306	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SLC6A11—melanoma	1.05e-05	0.000298	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIP4K2A—melanoma	1.05e-05	0.000298	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.05e-05	0.000298	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.04e-05	0.000296	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—MTAP—melanoma	1.02e-05	0.00029	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—VCAN—melanoma	1.01e-05	0.000289	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CG—melanoma	9.98e-06	0.000284	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PPARG—melanoma	9.63e-06	0.000274	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—LUM—melanoma	9.08e-06	0.000259	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PHGDH—melanoma	9.08e-06	0.000259	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—HPSE—melanoma	8.9e-06	0.000254	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CD—melanoma	8.77e-06	0.00025	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	8.76e-06	0.00025	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CUBN—melanoma	8.74e-06	0.000249	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ALB—melanoma	8.66e-06	0.000247	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP17A1—melanoma	8.55e-06	0.000243	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CSPG4—melanoma	8.44e-06	0.00024	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SDHD—melanoma	8.44e-06	0.00024	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—BSG—melanoma	8.44e-06	0.00024	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GPAM—melanoma	8.17e-06	0.000233	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GNA11—melanoma	8.07e-06	0.00023	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	7.91e-06	0.000225	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—FASN—melanoma	7.9e-06	0.000225	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SLC5A5—melanoma	7.77e-06	0.000221	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CB—melanoma	7.65e-06	0.000218	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PTGS2—melanoma	7.58e-06	0.000216	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GNAQ—melanoma	7.51e-06	0.000214	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CD44—melanoma	7.51e-06	0.000214	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP1B1—melanoma	7.2e-06	0.000205	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PLA2G6—melanoma	6.95e-06	0.000198	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PTEN—melanoma	6.61e-06	0.000188	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—VCAN—melanoma	6.24e-06	0.000178	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PRKCA—melanoma	5.45e-06	0.000155	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ERCC2—melanoma	5.41e-06	0.000154	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP17A1—melanoma	5.27e-06	0.00015	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GNA11—melanoma	4.97e-06	0.000142	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—FASN—melanoma	4.87e-06	0.000139	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SLC5A5—melanoma	4.79e-06	0.000136	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CA—melanoma	4.66e-06	0.000133	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GNAQ—melanoma	4.62e-06	0.000132	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CD44—melanoma	4.62e-06	0.000132	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP1B1—melanoma	4.43e-06	0.000126	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CG—melanoma	4.27e-06	0.000122	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PPARG—melanoma	4.12e-06	0.000117	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—AKT1—melanoma	3.81e-06	0.000108	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CD—melanoma	3.76e-06	0.000107	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ALB—melanoma	3.71e-06	0.000106	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ABCB1—melanoma	3.65e-06	0.000104	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PRKCA—melanoma	3.36e-06	9.57e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ERCC2—melanoma	3.33e-06	9.49e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CB—melanoma	3.27e-06	9.32e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PTGS2—melanoma	3.24e-06	9.24e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PTEN—melanoma	2.83e-06	8.06e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CG—melanoma	2.63e-06	7.5e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PPARG—melanoma	2.54e-06	7.23e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CD—melanoma	2.31e-06	6.59e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ALB—melanoma	2.28e-06	6.5e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CB—melanoma	2.02e-06	5.74e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PTGS2—melanoma	2e-06	5.69e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CA—melanoma	2e-06	5.68e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PTEN—melanoma	1.74e-06	4.96e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—AKT1—melanoma	1.63e-06	4.64e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CA—melanoma	1.23e-06	3.5e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—AKT1—melanoma	1e-06	2.86e-05	CbGpPWpGaD
